Last updated September 2024 - Hadassah Medical Center
1. Oren, I. et al. Helicobacter cinaedi Bacteremia in Children: A Case Report and Literature Review. Pediatr. Infect. Dis. J. 43, E135–E138 (2024).
2. Bulkowstein, Y. et al. The manifestations of metabolic acidosis during acetazolamide treatment in a cohort of pediatric idiopathic intracranial hypertension. Pediatr. Nephrol. 39, 185–191 (2024).
3. Ben-Moshe, Y. et al. Diagnostic Utility of Exome Sequencing Among Israeli Children With Kidney Failure. Kidney Int. Reports 8, 2126–2135 (2023).
4. Schnapp, A., Egger, Y., Bignall II, O. N. R., Issler, N. & Volovelsky, O. Estimated pediatric glomerular filtration rate presentation improves the detection rate of kidney impairment in children. Pediatr. Nephrol. 38, 3091–3097 (2023).
5. Amleh, A. et al. Arginine depletion attenuates renal cystogenesis in tuberous sclerosis complex model. Cell Reports Med. 4, (2023).
6. Lazarovits, G. et al. Acute Kidney Injury in Very Low Birth Weight Infants: A Major Morbidity and Mortality Risk Factor. Children 10, (2023).
7. Pode-Shakked, B. et al. A multidisciplinary nephrogenetic referral clinic for children and adults—diagnostic achievements and insights. Pediatr. Nephrol. 37, 1623–1646 (2022).
8. Hassan, A. et al. Molecular Mechanisms of Parathyroid Disorders in Chronic Kidney Disease. Metabolites 12, (2022).
9. Makayes, Y. et al. Increasing mtorc1 pathway activity or methionine supplementation during pregnancy reverses the negative effect of maternal malnutrition on the developing kidney. J. Am. Soc. Nephrol. 32, 1898–1912 (2021).
10. Nitzan-Luques, A. et al. Neonatal thrombotic microangiopathy secondary to factor I variant with Hirschsprung disease. J. Nephrol. 34, 241–245 (2021).
11. Yahalom, C. et al. SENIOR-LØKEN SYNDROME: A Case Series and Review of the Renoretinal Phenotype and Advances of Molecular Diagnosis. Retina 41, 2179–2187 (2021).
12. Dayan, R. R., Ray Bignall Ii, O. N., Johnson, S., Flores, F. & Volovelsky, O. Neuroblastoma Amplified Sequence Gene Mutations Inducing Acute Kidney and Liver Injury in an Adolescent Female. Case Reports Nephrol. Dial. 10, 117–123 (2020).
13. Nechama, M., Makayes, Y., Resnick, E., Meir, K. & Volovelsky, O. Rapamycin and dexamethasone during pregnancy prevent tuberous sclerosis complex–associated cystic kidney disease. JCI Insight 5, (2020).
14. Naveh-Many, T. & Volovelsky, O. Parathyroid cell proliferation in secondary hyperparathyroidism of chronic kidney disease. Int. J. Mol. Sci. 21, 1–17 (2020).
15. Zahr, R. S. et al. Kidney biopsy findings in children with sickle cell disease: a Midwest Pediatric Nephrology Consortium study. Pediatr. Nephrol. 34, 1435–1445 (2019).
16. Volovelsky, O. et al. Pre-operative level of FGF23 predicts severe acute kidney injury after heart surgery in children. Pediatr. Nephrol. 33, 2363–2370 (2018).
17. Volovelsky, O. et al. Early postoperative measurement of fibroblast growth factor 23 predicts severe acute kidney injury in infants after cardiac surgery. Clin. Nephrol. 90, 165–171 (2018).
18. Volovelsky, O. et al. Hamartin regulates cessation of mouse nephrogenesis independently of Mtor. Proc. Natl. Acad. Sci. U. S. A. 115, 5998–6003 (2018).
19. Atreya, M. R., Jaberi, N. A., Claes, D. J. & Volovelsky, O. Skin discoloration, methemoglobinemia, and acute interstitial nephritis in a 15-year-old girl. Pediatr. Rev. 38, 389 (2017).
20. Volovelsky, O. & Kopan, R. Making new kidneys: On the road from science fiction to science fact. Curr. Opin. Organ Transplant. 21, 574–580 (2016).
21. Volovelsky, O. et al. Phosphorylation of ribosomal protein S6 mediates mammalian target of rapamycin complex 1-induced parathyroid cell proliferation in secondary hyperparathyroidism. J. Am. Soc. Nephrol. 27, 1091–1101 (2016).
22. Abramovitch, S. et al. Vitamin D inhibits development of liver fibrosis in an animal model but cannot ameliorate established cirrhosis. Am. J. Physiol. - Gastrointest. Liver Physiol. 308, G112–G120 (2015).
23. Volovelsky, O., Gross, E. & Shteyer, E. Appendicular foreign body: Patience needed. J. Pediatr. Surg. 48, 454–455 (2013).
24. Volovelsky, O. & Weiss, R. Fatty liver disease in obese children relation to other metabolic risk factors. Int. J. Pediatr. Obes. 6, 59–64 (2011).